MedPath

Comparison of efficacy and safety of topical 5% potassium hydroxide solution and topical 0.1% retinoid lotion in the treatment of plane wart

Not Applicable
Conditions
plane wart.
Viral infections characterized by skin and mucous membrane lesions
B00-B09
Registration Number
IRCT201201038516N2
Lead Sponsor
The institute of research and technology of Ahvaz jundishapur University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Inclusion criterion: presence of at least three lesion
Exclusion criteria:
1-Pregnancy
2-Lactation
3-Patients that have received treatment in the recent four weeks
4-Secondary infection
5-Involvement of the genital area

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement. Timepoint: 2 weeks, 4 weeks, 6 weeks after initiation of the treatment and 2 weeks after the end of the treatment. Method of measurement: Based on the count of lesions.
Secondary Outcome Measures
NameTimeMethod
Adverse drug reaction. Timepoint: 2 weeks, 4 weeks, 6 weeks after the initiation of the treatment and 2 weeks after the end of the treatment. Method of measurement: Based on occurrence of various adverse reaction.
© Copyright 2025. All Rights Reserved by MedPath